EXERCISE AND FITNESS IN CHILDHOOD CANCER SURVIVORS
儿童癌症幸存者的锻炼和健身
基本信息
- 批准号:7603552
- 负责人:
- 金额:$ 0.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-01 至 2007-09-16
- 项目状态:已结题
- 来源:
- 关键词:Aerobic ExerciseCancer SurvivorshipComputer Retrieval of Information on Scientific Projects DatabaseConditionCoupledDEXAEducationEducational MaterialsExclusion CriteriaExerciseFundingGrantHealthInstitutionInterventionLong-Term SurvivorsOutcome MeasurePhysical FunctionPhysical activityRandomizedResearchResearch PersonnelResourcesScanningSourceStandards of Weights and MeasuresSurvivorsTrainingUnited States National Institutes of HealthWeekcancer typechildhood cancer survivorfitnessfollow-uphealth related quality of lifeprograms
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Long-term survivors of several cancer types who meet the inclusion and exclusion criteria will be randomized to either the Intervention Condition (IC), or to the Control Condition (CC). The Intervention Condition combines a formalized program of exercise training, provided in an individualized format with the standard educational material provided in our ACCESS cancer survivorship program. The Control Condition includes provision of educational material, without a formal exercise program. Both groups will also continue whatever physical activities the survivor might normally engage in. 20 subjects will be assigned to each condition. IC subjects will receive a 12 weeklong aerobic exercise and physical activity program, coupled with health and fitness education. CC subjects will receive only the health and fitness education. Primary outcome measures, including DEXA scans, will be administered to both the IC and CC subjects at the beginning (week 0) and the end of the intervention (week 12), and again at three-month follow-up (week 24). The primary outcome measures will violate specific aspects of physical functioning and health-related quality of life.
该副本是利用众多研究子项目之一
由NIH/NCRR资助的中心赠款提供的资源。子弹和
调查员(PI)可能已经从其他NIH来源获得了主要资金,
因此可以在其他清晰的条目中代表。列出的机构是
对于中心,这不一定是调查员的机构。
符合纳入和排除标准的几种癌症类型的长期幸存者将被随机分为干预条件(IC)或控制条件(CC)。 干预条件结合了一个以个性化格式提供的正式运动培训计划,以及我们的访问癌症生存计划中提供的标准教育材料。 控制条件包括提供教育材料,没有正式的锻炼计划。 这两个小组还将继续任何幸存者通常从事的身体活动。将为每种情况分配20名受试者。 IC受试者将获得一项为期12周的有氧运动和体育锻炼计划,再加上健康和健身教育。 CC受试者将仅接受健康和健身教育。 包括DEXA扫描在内的主要结局指标将在开始时(第0周)和干预结束(第12周),然后在三个月的随访(第24周)中对IC和CC受试者进行管理。 主要结果指标将违反身体功能和与健康相关的生活质量的特定方面。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Debra L. Friedman其他文献
Insurance, Financial Strain, Family Function, and Psychosocial Wellbeing in Pediatric Patients and Parents with Hematologic Malignancies
- DOI:
10.1182/blood-2024-207908 - 发表时间:
2024-11-05 - 期刊:
- 影响因子:
- 作者:
Nadia Syed;Stacie Dusetzina;Tatsuki Koyama;Emma Schremp;Meredith Smalls;Debra L. Friedman - 通讯作者:
Debra L. Friedman
Verapamil and valproic acid treatment of prolonged mania.
维拉帕米和丙戊酸治疗长期躁狂。
- DOI:
10.1097/00004583-199203000-00014 - 发表时间:
1992 - 期刊:
- 影响因子:13.3
- 作者:
Ted Kastner;Debra L. Friedman - 通讯作者:
Debra L. Friedman
Applying a risk prediction model for bloodstream infection in a febrile, nonseverely neutropenic cohort of pediatric stem cell transplant patients
在发热、非严重中性粒细胞减少儿科干细胞移植患者队列中应用血流感染风险预测模型
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:6.2
- 作者:
Kasey Jackson;Victoria Anderson;Zhiguo Zhao;C. Kitko;J. Connelly;R. Ho;Ritu Banerjee;D. Dulek;Debra L. Friedman;A. Esbenshade - 通讯作者:
A. Esbenshade
Monitoring diagnostic accuracy and complications. A report from the Children's Oncology Group Hodgkin lymphoma study
- DOI:
10.1016/j.jpedsurg.2006.12.030 - 发表时间:
2007-05-01 - 期刊:
- 影响因子:
- 作者:
Peter F. Ehrlich;Debra L. Friedman;Cynthia L. Schwartz; Children Oncology Group Hodgkin Lymphoma study section - 通讯作者:
Children Oncology Group Hodgkin Lymphoma study section
Comparison of outcomes, adverse events, and treatment burden of intravenous chemotherapy versus intra-arterial chemotherapy for retinoblastoma: results of a pilot study
- DOI:
10.1016/j.jaapos.2019.08.031 - 发表时间:
2019-08-01 - 期刊:
- 影响因子:
- 作者:
Pranav R. Santapuram;Jessica L. Burris;Debra L. Friedman;Tatsuki Koyama;Anthony B. Daniels - 通讯作者:
Anthony B. Daniels
Debra L. Friedman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Debra L. Friedman', 18)}}的其他基金
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
因果关系:增强对整个生命周期肉瘤幸存者的理解的队列
- 批准号:
10900883 - 财政年份:2021
- 资助金额:
$ 0.42万 - 项目类别:
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
因果关系:增强对整个生命周期肉瘤幸存者的理解的队列
- 批准号:
10212723 - 财政年份:2021
- 资助金额:
$ 0.42万 - 项目类别:
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)
通过远程医疗和参与加强农村居民的癌症护理 (ENCORE)
- 批准号:
10668344 - 财政年份:2019
- 资助金额:
$ 0.42万 - 项目类别:
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)
通过远程医疗和参与加强农村居民的癌症护理 (ENCORE)
- 批准号:
9788880 - 财政年份:2019
- 资助金额:
$ 0.42万 - 项目类别:
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)
通过远程医疗和参与加强农村居民的癌症护理 (ENCORE)
- 批准号:
10208824 - 财政年份:2019
- 资助金额:
$ 0.42万 - 项目类别:
Research Into Visual Endpoints and RB Health Outcomes After Treatment: The RIVERBOAT Consortium
视觉终点和 RB 治疗后健康结果的研究:RIVERBOAT 联盟
- 批准号:
9755391 - 财政年份:2018
- 资助金额:
$ 0.42万 - 项目类别:
Research Into Visual Endpoints and RB Health Outcomes After Treatment: The RIVERBOAT Consortium
视觉终点和 RB 治疗后健康结果的研究:RIVERBOAT 联盟
- 批准号:
10473688 - 财政年份:2018
- 资助金额:
$ 0.42万 - 项目类别:
Research Into Visual Endpoints and RB Health Outcomes After Treatment: The RIVERBOAT Consortium
视觉终点和 RB 治疗后健康结果的研究:RIVERBOAT 联盟
- 批准号:
10669063 - 财政年份:2018
- 资助金额:
$ 0.42万 - 项目类别:
Conducting Research in Pediatric Hematology/Oncology
进行儿科血液学/肿瘤学研究
- 批准号:
8547785 - 财政年份:2011
- 资助金额:
$ 0.42万 - 项目类别:
Telephone Counseling - Caregivers for Children with Cancer
电话咨询 - 癌症儿童的护理人员
- 批准号:
8339427 - 财政年份:2011
- 资助金额:
$ 0.42万 - 项目类别:
相似国自然基金
基于伴有生存时间离散选择实验的中国癌症人群FACT-8D健康效用积分体系构建及性能评估研究
- 批准号:72274045
- 批准年份:2022
- 资助金额:45 万元
- 项目类别:面上项目
面向多组学癌症数据的多视图生存分析算法的研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRT和CTT模型的癌症生存者营养素养测评工具构建与应用研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRT和CTT模型的癌症生存者营养素养测评工具构建与应用研究
- 批准号:82103966
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
癌症生存者心血管健康关键风险因素多维识别、智能预警与防控管理
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
NEUROCOGNITIVE PROGNOSIS IN SURVIVORS OF BRAIN TUMORS
脑肿瘤幸存者的神经认知预后
- 批准号:
7951249 - 财政年份:2009
- 资助金额:
$ 0.42万 - 项目类别:
GENETIC DISSECTION OF INSULIN RESISTANCE IN CANCER AND METABOLIC FUNCTION
癌症中胰岛素抵抗和代谢功能的基因剖析
- 批准号:
7956485 - 财政年份:2009
- 资助金额:
$ 0.42万 - 项目类别:
GENETIC DISSECTION OF INSULIN RESISTANCE IN CANCER AND METABOLIC FUNCTION
癌症中胰岛素抵抗和代谢功能的基因剖析
- 批准号:
7723450 - 财政年份:2008
- 资助金额:
$ 0.42万 - 项目类别:
NEUROCOGNITIVE PROGNOSIS IN SURVIVORS OF BRAIN TUMORS
脑肿瘤幸存者的神经认知预后
- 批准号:
7625772 - 财政年份:2007
- 资助金额:
$ 0.42万 - 项目类别: